Major Funds Exit Mednax Holdings Despite Stock Surge

Mednax US58502B1061

While Mednax shares have demonstrated remarkable strength in recent months, significant institutional players are quietly reducing their exposure. Recent regulatory filings reveal substantial position trimming by Boston Partners and Geode Capital Management, creating a concerning backdrop to the stock’s impressive rally.

Adding to the institutional exodus, corporate insiders have been active sellers in November 2025. Recent disclosures show two directors capitalizing on current price levels:

• November 17: Director Michael Rucker disposed of 10,478 shares at $23.00 each, generating total proceeds of $240,994
• November 6: Director Laura Linynsky sold 10,000 shares at $21.65 per share, realizing $216,500